Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14605997rdf:typepubmed:Citationlld:pubmed
pubmed-article:14605997lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0015663lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0202041lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0332464lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0441994lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C2827424lld:lifeskim
pubmed-article:14605997lifeskim:mentionsumls-concept:C0061359lld:lifeskim
pubmed-article:14605997pubmed:issue10lld:pubmed
pubmed-article:14605997pubmed:dateCreated2003-11-7lld:pubmed
pubmed-article:14605997pubmed:abstractTextTo evaluate the safety and efficacy of various doses of recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered subcutaneously (s. c.) via bolus injection or continuous infusion to lower fasting serum glucose (FSG) levels in subjects with type 2 diabetes treated by diet, hypoglycemic drugs, or insulin injection.lld:pubmed
pubmed-article:14605997pubmed:languageenglld:pubmed
pubmed-article:14605997pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:citationSubsetIMlld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14605997pubmed:statusMEDLINElld:pubmed
pubmed-article:14605997pubmed:monthOctlld:pubmed
pubmed-article:14605997pubmed:issn0018-5043lld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:SchneiderRRlld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:KlaffL JLJlld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:KayH DHDlld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:EhlersM RMRlld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:D'AlessioD...lld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:BrazgRRlld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:HarleyR ERElld:pubmed
pubmed-article:14605997pubmed:authorpubmed-author:MathisenA LALlld:pubmed
pubmed-article:14605997pubmed:issnTypePrintlld:pubmed
pubmed-article:14605997pubmed:volume35lld:pubmed
pubmed-article:14605997pubmed:ownerNLMlld:pubmed
pubmed-article:14605997pubmed:authorsCompleteYlld:pubmed
pubmed-article:14605997pubmed:pagination611-6lld:pubmed
pubmed-article:14605997pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:meshHeadingpubmed-meshheading:14605997...lld:pubmed
pubmed-article:14605997pubmed:year2003lld:pubmed
pubmed-article:14605997pubmed:articleTitleRecombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes.lld:pubmed
pubmed-article:14605997pubmed:affiliationRestoragen, Inc., Lincoln, Nebraska, USA. marioe@pacbio.comlld:pubmed
pubmed-article:14605997pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14605997pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14605997pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:14605997pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:14605997pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed